167 related articles for article (PubMed ID: 28713902)
1. Establishment and characterization of cell lines derived from complete hydatidiform mole.
Yamamoto E; Niimi K; Kiyono T; Yamamoto T; Nishino K; Nakamura K; Kotani T; Kajiyama H; Shibata K; Kikkawa F
Int J Mol Med; 2017 Sep; 40(3):614-622. PubMed ID: 28713902
[TBL] [Abstract][Full Text] [Related]
2. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblasts.
Ladines-Llave CA; Maruo T; Manalo AM; Mochizuki M
Cancer; 1993 Jun; 71(12):4118-23. PubMed ID: 7685239
[TBL] [Abstract][Full Text] [Related]
4. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
5. p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole.
Qiao S; Nagasaka T; Harada T; Nakashima N
Placenta; 1998; 19(5-6):361-9. PubMed ID: 9699956
[TBL] [Abstract][Full Text] [Related]
6. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
Cui JQ; Shi YF; Zhou HJ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
[TBL] [Abstract][Full Text] [Related]
7. Trophoblastic debris extruded from hydatidiform molar placentae activates endothelial cells: Possible relevance to the pathogenesis of preeclampsia.
Zhao M; Yin Y; Wei J; Wu M; Yang C; Chen Q
Placenta; 2016 Sep; 45():42-9. PubMed ID: 27577709
[TBL] [Abstract][Full Text] [Related]
8. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
[TBL] [Abstract][Full Text] [Related]
11. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
[TBL] [Abstract][Full Text] [Related]
12. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
Persaud V; Ganjei P; Nadji M
West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
[TBL] [Abstract][Full Text] [Related]
15. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of a tumor necrosis factor receptor-related transcript in gestational trophoblastic diseases in women.
Dumur CI; Koritschoner NP; Flury A; Panzetta-Dutari G; Bocco JL; Patrito LC
Biol Reprod; 1998 Sep; 59(3):621-5. PubMed ID: 9716562
[TBL] [Abstract][Full Text] [Related]
17. p53 expression in placentas with hydropic change and hydatidiform moles.
Cheville JC; Robinson RA; Benda JA
Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
[TBL] [Abstract][Full Text] [Related]
18. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases.
Abdou A; Kandil M; El-Wahed MA; Shabaan M; El-Sharkawy M
Fetal Pediatr Pathol; 2013 Dec; 32(6):395-411. PubMed ID: 23438793
[TBL] [Abstract][Full Text] [Related]
20. Identification of multiple differentially expressed messenger RNAs in normal and pathological trophoblast.
Durand S; Abadie P; Angeletti S; Genti-Raimondi S
Placenta; 2003; 24(2-3):209-18. PubMed ID: 12566248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]